全球透明质酸皮肤填充剂市场规模、份额、成长分析、按产品类型、按应用划分 - 产业预测，2024-2031 年

Global Hyaluronic Acid Based Dermal Fillers Market Size, Share, Growth Analysis, By Product Type(Single phase and duplex products), By Application(Wrinkle correction, lip augmentation) - Industry Forecast 2024-2031

出版日期: 2024年03月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球透明质酸皮肤填充剂市场规模为42.2亿美元，从2023年的46亿美元增长到2031年的94.2亿美元，预计在预测期内（2024-2031年）将持续增长。预计维持在9.10%。

对非侵入性美容手术的需求迅速增长，加上人们对透明质酸 (HA) 在美容领域的多种用途的认识不断增强，正在推动市场扩张。这一趋势的推动因素是创新真皮产品研发投资的增加，以及越来越关注老龄化对其外观影响的男性整容手术的趋势，进一步增强。以 2021 年推出的雷射表面置换疗程为代表的技术进步正在改变游戏规则，为各种皮肤问题提供高效、微创的解决方案，同时满足对非侵入性技术的需求。我让你做到。市场领导正在优先开发先进的解决方案以保持竞争力，包括最近 FDA核准的 RHA Redenth，这是一种突破性的皮肤填充剂，旨在减少皱纹和细纹。新产品的核准正在激增。然而，美国、欧盟等主要市场的严格政府法规对规范透明质酸产品的开发、品牌和生产提出了挑战。然而，儘管存在这些障碍，在美容手术需求不断增长和持续技术创新的推动下，全球市场仍有望显着成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Allergan（US）
Galderma Laboratories LP（Switzerland）
Merz Pharmaceuticals（Germany）
Genzyme Corporation（US）
Anika Therapeutics Inc.（US）
LG Life Sciences, LTD（LG Chem）（South Korea）
Bio plus Co. Ltd.（South Korea）
Sculpt Luxury Dermal Fillers Ltd（UK）
Bioxis Pharmaceutical（France）
Sinclair Pharma（UK）
Laboratories Vivacy（France）
Bohus Biotech AB（Sweden）
Croma-Pharma GmbH（Austria）
Teoxane（Switzerland）
Hyaltech Ltd.（Israel）
Galatea Surgical（US）
Medytox（South Korea）
Suneva Medical（US）
Laboratoires Filorga（France）
Regen Lab SA（Switzerland）

简介目录

Product Code: SQMIG35H2096

Global Hyaluronic Acid Based Dermal Fillers Market size was valued at USD 4.22 billion in 2022 and is poised to grow from USD 4.60 billion in 2023 to USD 9.42 billion by 2031, growing at a CAGR of 9.10 % during the forecast period (2024-2031).

The surge in demand for non-invasive aesthetic procedures, coupled with a growing awareness of the versatile applications of Hyaluronic Acid (HA) in the beauty sector, is propelling market expansion. This momentum is further bolstered by increased investments in research and development for innovative dermal products and a rising trend of aesthetic procedures among men, who are increasingly mindful of the aging process's impact on their appearance. Technological advancements, exemplified by the introduction of laser resurfacing treatments in 2021, are revolutionizing the landscape by offering efficient solutions to various skin concerns with reduced invasiveness, meeting the demand for non-invasive techniques. Market leaders are prioritizing the development of advanced solutions to maintain a competitive edge, with a surge in new product approvals, including recent FDA approval for RHA Redensity, a groundbreaking dermal filler aimed at reducing wrinkles and lines. However, stringent government regulations in key markets like the U.S., European Union, and others present challenges, governing the development, branding, and production of HA-based products. Nonetheless, despite these obstacles, the global market is poised for significant growth, fueled by increasing demand for aesthetic procedures and ongoing technological innovations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyaluronic Acid Based Dermal Fillers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hyaluronic Acid Based Dermal Fillers Market Segmental Analysis

A significant factor propelling the Global Hyaluronic Acid Based Dermal Fillers Market is the rising interest in non-invasive aesthetic treatments, spurred by heightened consumer awareness, a quest for youthful looks, and advancements in hyaluronic acid-based therapies. This surge in demand is not only stimulating market expansion but also presenting lucrative prospects for industry participants.

Drivers of the Global Hyaluronic Acid Based Dermal Fillers Market

Technological advancements stand as a paramount force propelling the Global Hyaluronic Acid Based Dermal Fillers Market forward. The ongoing progress in technology, encompassing breakthroughs in data analytics, artificial intelligence, and blockchain, has profoundly bolstered the expansion and efficacy of P2P lending platforms. These advancements have streamlined loan application procedures, fortified credit evaluation capacities, refined risk management frameworks, and delivered effortless user interactions for borrowers and lenders alike. Through the integration of cutting-edge technologies, the P2P lending sphere has broadened its outreach, rendering it more accessible, efficient, and attractive to a broader spectrum of participants.

Restraints in the Global Hyaluronic Acid Based Dermal Fillers Market

The elevated expense linked with surgical procedures stands as a significant impediment for the Global Hyaluronic Acid Based Dermal Fillers Market. Despite an increasing desire for aesthetic enhancements, the financial aspect poses a barrier for certain individuals, constraining their ability to avail themselves of such treatments. This cost factor could impede market expansion, particularly in areas where both affordability and accessibility remain key concerns for a substantial portion of the populace.

Market Trends of the Global Hyaluronic Acid Based Dermal Fillers Market

A notable market trend in the Global Hyaluronic Acid Based Dermal Fillers Market involves integrating lidocaine, a local anesthetic, into the fillers, with the goal of augmenting patient comfort during procedures by minimizing potential discomfort or pain. Numerous companies within the market have launched HA-based fillers containing lidocaine, acknowledging the significance of delivering a more pleasant experience for patients. This trend is in line with the increasing emphasis on enhancing patient satisfaction and refining treatment outcomes within the realm of aesthetic procedures.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Hyaluronic Acid Based Dermal Fillers Market by Product Type

Market Overview
Single phase and duplex products

Global Hyaluronic Acid Based Dermal Fillers Market by Application

Market Overview
Wrinkle correction
lip augmentation
rhinoplasty and others

Global Hyaluronic Acid Based Dermal Fillers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Allergan (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma Laboratories L.P. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharmaceuticals (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genzyme Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LG Life Sciences, LTD (LG Chem) (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio plus Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sculpt Luxury Dermal Fillers Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioxis Pharmaceutical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinclair Pharma (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratories Vivacy (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bohus Biotech AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Croma-Pharma GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teoxane (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hyaltech Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galatea Surgical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medytox (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoires Filorga (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments